dextrothyroxine has been researched along with HTLV-I Infections in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Angheben, A; Bisoffi, Z; Bon, I; Buonfrate, D; Lunardi, G; Pomari, E; Rodari, P | 1 |
| Chiodini, PL; Gration, B; Martyn, E; Somasundaram, C | 1 |
| Ashida, C; Funauchi, M; Kinoshita, K; Nozaki, Y | 1 |
| Hashiba, Y; Hidaka, T; Kawano, A; Maruyama, H; Minami, H; Nagayasu, E; Okayama, A; Umekita, K | 1 |
| Alcântara de Souza Melo, PF; Bottasso, O; Brandão, E; Ramos Araújo, PS; Regueira Fernandes, A; Rocha, A; Romero, S | 1 |
| Chung, H; Shiiki, S; Shimasaki, T | 1 |
| Asif, M; Choksi, TT; Clarke, L; Danilewitz, M; Dar, T; Fleming, K; Hennawy, R; Madison, G | 1 |
| Fujita, J; Higashiarakawa, M; Hirata, T; Hokama, A; Kinjo, T; Naka, H; Parrott, G; Tanaka, T | 1 |
| Arch, EL; Dahiya, A; Schaefer, JT | 1 |
| Faught, C; McCarthy, AE; Peters, L | 1 |
| Camara, P; Colbacchini, P; Hovette, P; Lejean, Y; Lô, N; Tuan, JF | 1 |
| Akiyama, Y; Mitsunaga, M; Miyauchi, N; Saima, S | 1 |
| Hirata, T; Kinjo, F; Saito, A; Uchima, N; Zaha, O | 1 |
| Duwe, S; Ellerbrok, H; Pauli, G; Poggensee, G; Richter, J; Schwarz, U | 1 |
| Fujita, J; Hirata, T; Hokama, A; Kinjo, F; Kinjo, N; Kishimoto, K; Sakugawa, H; Uchima, N; Zaha, O | 1 |
| Baccard, M; Cordoliani, F; Feuilhade de Chauvin, M; Fournier, S; Morel, P; Tancrede, E; Vasseur, E | 1 |
| Kobayashi, J; Sato, Y; Shimabukuro, I; Shiroma, Y; Takara, M; Toma, H | 1 |
| Alvarez, H; Freedman, DO; Gotuzzo, E; Infante, R; Tello, R; Terashima, A | 1 |
| Bouhali, R; Breuil, J; Chapuis, L; Courillon-Mallet, A; Lafaix, C; Patey, O | 1 |
2 review(s) available for dextrothyroxine and HTLV-I Infections
| Article | Year |
|---|---|
[Clinical and epidemiological characteristics of strongyloidiasis in patients with comorbidities].
Topics: Alcoholism; Animals; Antiparasitic Agents; Comorbidity; Diabetes Mellitus; Female; HIV Infections; HTLV-I Infections; Humans; Ivermectin; Male; Middle Aged; Organ Transplantation; Risk Factors; Stomach Neoplasms; Strongyloidiasis; Thiabendazole | 2017 |
Arthritis associated with Strongyloides stercoralis.
Topics: Adult; Arthritis, Infectious; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Feces; Female; HTLV-I Infections; Humans; Ivermectin; Male; Recurrence; Strongyloidiasis; Thiabendazole; Time Factors; Uveitis | 1990 |
2 trial(s) available for dextrothyroxine and HTLV-I Infections
| Article | Year |
|---|---|
Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody.
Topics: Administration, Oral; Animals; Anthelmintics; Drug Administration Schedule; Female; HTLV-I Antibodies; HTLV-I Infections; Humans; Ivermectin; Male; Middle Aged; Strongyloidiasis; Treatment Outcome | 2004 |
Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan.
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Animals; Antinematodal Agents; Drug Administration Schedule; Female; HTLV-I Infections; Humans; Ivermectin; Japan; Male; Middle Aged; Pyrvinium Compounds; Strongyloides stercoralis; Strongyloidiasis | 2000 |
15 other study(ies) available for dextrothyroxine and HTLV-I Infections
| Article | Year |
|---|---|
Ivermectin concentration in breastmilk of a woman with Strongyloides stercoralis and human T-lymphotropic virus-I co-infection.
Topics: Adult; Animals; Breast Feeding; Coinfection; Female; HTLV-I Infections; Humans; Ivermectin; Milk, Human; Neglected Diseases; Strongyloides stercoralis; Strongyloidiasis | 2020 |
Topics: Abdominal Pain; Aged, 80 and over; Animals; Anorexia; Antiparasitic Agents; Feces; HTLV-I Infections; Humans; Intestinal Obstruction; Ivermectin; Male; Strongyloides stercoralis; Strongyloidiasis; Treatment Outcome; Weight Loss | 2019 |
Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Topics: Aged; Animals; Anthelmintics; Antiviral Agents; Coinfection; Cytomegalovirus; Cytomegalovirus Infections; Fatal Outcome; Female; Ganciclovir; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Ivermectin; Lupus Erythematosus, Systemic; Strongyloides stercoralis; Strongyloidiasis; Syndrome | 2020 |
Topics: Aged; Animals; Antiparasitic Agents; Arthritis, Rheumatoid; Colitis, Ulcerative; Female; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunosuppressive Agents; Ivermectin; Strongyloides stercoralis; Strongyloidiasis; Tumor Necrosis Factor Inhibitors | 2021 |
Five cases of recurrent meningitis associated with chronic strongyloidiasis.
Topics: Adult; Aged; Anthelmintics; Chronic Disease; Female; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Ivermectin; Male; Meningitis, Bacterial; Middle Aged; Retrospective Studies; Strongyloidiasis; Thiabendazole; Young Adult | 2015 |
Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.
Topics: Albendazole; Animals; Antiparasitic Agents; Coinfection; Enterocolitis, Pseudomembranous; Gram-Negative Bacterial Infections; Herpes Labialis; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Ivermectin; Klebsiella Infections; Male; Meningitis, Bacterial; Middle Aged; Multiple Organ Failure; Pneumonia, Bacterial; Respiratory Insufficiency; Strongyloides stercoralis; Strongyloidiasis | 2016 |
Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
Topics: Age Factors; Aged; Animals; Antibodies, Helminth; Antinematodal Agents; Asymptomatic Infections; Coinfection; Diagnosis, Differential; Eosinophils; Female; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunoglobulin E; Ivermectin; Leukocyte Count; Male; Middle Aged; Sex Factors; Strongyloides stercoralis; Strongyloidiasis | 2017 |
Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
Topics: Abdomen; Administration, Rectal; Adult; Animals; Antiparasitic Agents; Female; HTLV-I Infections; Humans; Intubation, Gastrointestinal; Ivermectin; Leg; Purpura; Skin; Strongyloides stercoralis; Strongyloidiasis; Treatment Outcome | 2008 |
Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
Topics: Adult; Animals; Antinematodal Agents; Chemoprevention; Fatal Outcome; Female; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Ivermectin; Leukemia, T-Cell; Lymphoma, Non-Hodgkin; Male; Strongyloides stercoralis; Strongyloidiasis | 2009 |
[Pulmonary strongyloidiasis complicated by E. coli meningitis in a HIV-1 and HTLV-1 positive patient].
Topics: Antinematodal Agents; HIV Infections; HIV-1; HTLV-I Infections; Humans; Immunocompromised Host; Ivermectin; Lung Diseases; Male; Meningitis, Escherichia coli; Middle Aged; Prognosis; Strongyloidiasis | 2002 |
[A case of strongyloidiasis hyperinfection during oral corticosteroid therapy associated with a nephrotic patient infected with HTLV-1].
Topics: Aged; Antinematodal Agents; Glomerulonephritis; HTLV-I Infections; Humans; Ivermectin; Male; Prednisolone; Strongyloidiasis; Superinfection | 2003 |
[Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
Topics: Albendazole; Animals; Anthelmintics; Feces; Fever; Germany; Guinea; Headache; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Ivermectin; Male; Middle Aged; Neck Pain; Parasite Egg Count; Phylogeny; Pruritus; Strongyloides stercoralis; Strongyloidiasis; Travel | 2005 |
Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Topics: Adolescent; Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Animals; Anthelmintics; Child; Child, Preschool; Comorbidity; Female; HTLV-I Antibodies; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunoglobulin G; Infant; Ivermectin; Japan; Male; Middle Aged; Prevalence; Prospective Studies; Sex Factors; Strongyloides stercoralis; Strongyloidiasis | 2006 |
Ivermectin-responsive crusted scabies in HTLV1 carrier.
Topics: Aged; Aged, 80 and over; Antiparasitic Agents; Female; HTLV-I Infections; Humans; Immunocompromised Host; Ivermectin; Scabies; Scalp Dermatoses; Viremia | 1996 |
Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection.
Topics: Adolescent; Adult; Animals; Antinematodal Agents; Blotting, Western; Child; Enzyme-Linked Immunosorbent Assay; Feces; Female; HTLV-I Infections; Humans; Intestinal Diseases, Parasitic; Ivermectin; Male; Middle Aged; Strongyloides stercoralis; Strongyloidiasis; Thiabendazole; Treatment Failure | 2002 |